This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

February 27-28, 2020
Westin Miyako Kyoto,
Kyoto, Japan

Advanced Strategies for Navigating a Complex Regulatory Landscape and Managing High-Priority Risks in the Asia-Pacific Region

The only event for compliance teams, to benchmark, exchange ideas and learn about impact of the latest laws and regulations surrounding bribery and corruption, HCP sponsorships, transparency, data privacy, promotional activities, third-party management and more.

What to Expect

Expertise from Leading Life Sciences Companies

Yutaka Mitsutake, Compliance Business Partner, AstraZeneca K.K. 

Catherine Healy Kanzler, Head of Global Compliance Operations, Olympus Corporation

Justus Chua, Head of Legal and Compliance – South East Asia & South Korea, Boehringer Ingelheim

Asif Usmani, Regional Franchise & FEM Compliance Head, APAC, Alcon Pte Ltd

Agatha L. O’Malley, Global Data Protection Officer, Otsuka Pharmaceutical, Inc.

Koichiro Miyata, Senior Director and General Counsel, Medtronic

Tali Guy, Vice President Compliance, Third Party Due Diligence & Global R&D Compliance Officer, Teva Pharmaceuticals

End-to-End Compliance for Critical Activities
  • Examine strategies for conducting due diligence on third-parties and distributors
  • Assess best practices for enhancing the risk assessment process and automating monitoring/auditing
  • Learn about recent enforcement actions and best practices for tightening internal controls
  • Exchange ideas for overseeing vendor management from selection to renewal
  • Gain an understanding of the general trends with cross-border HCP engagements and consent management
Innovation and its Impact on Compliance
  • Learn about advancements in the industry and use cases
  • Benefit from a primer on cybersecurity and review the governance considerations
  • Discuss machine learning, pattern recognition and natural language processing to help detect and monitor risk

Participants from Around the World